‘From of control’: Small Australian company incorrectly named as Taliban hash partner

SYDNEY, Nov. 25 (Reuters) – A small Australian medical consultancy caught up in an unexpected publicity storm on Thursday after being wrongly named as an agreement with Afghan ruling Taliban to fund $450 million hash processing plant in the Central Asian country.

A report by Afghan Pajhwok Afghan News said representatives of It in Australia-based Cpharm had met with drug control officials at the ministry of Interior for the production of medicines and creams in to discuss the factory, met a legal one use of cannabis, die there is widespread.

The report has been chosen up by a host of global outlets, including the Times of London that its own story naming of the Australian company. Verified Twitter accounts linked to the BBC and the Middle East news outlet Al Arabybia repeated the claim over the Australians.

register now for FREE unlimited access to reuters.com

But Cpharm Australia, a family business with 17 employees of the regional center of Maitland, never has met spoke to the Taliban and did not do business overseas of met cannabis, it told Reuters.

“Goods just to attempt work out what we’re going to do to stop it,” Cpharm Australia’s chief financial officer, Tony Gabites, said by telephone from the company’s headquarters, located 166 km (100 miles) from Sydney.

“We probably have 40 . today of had 50 calls. It is… just out of control and it is just all lies, media guys … don’t do due diligence on What she want publish,” he said.

Gabites suspected the reports stemmed from a tweet from a Taliban-linked account mentioning a company called Cpharm, referring to another organization elsewhere. in the world with a similar name.

Cpharm Australia provides medical advice over pharmaceuticals and is not a manufacturer so would not take it on a production contract in any case. It also should not in be able to raise $450 million, Gabites added.

The company can take legal action if it loses business due to falsely reported Taliban transactions – a possible violation of sanctions – but didn’t expect to be affected for long -term.

“Most of the companies we do business with with would look at that article and laugh,” said Gabites.

register now for FREE unlimited access to reuters.com

Reporting by Byron Kaye; Editing by Leslie Adler

Our standards: The Thomson Reuters Trust Principles.

Read More: World News


Denial of any Responsibility!
AsumeTech is a News Source that Publishes News from its Editorial Team and the Automatic News Aggregation around the News Media. All the Aggregated Content you find on our site is available freely over the Internet; each piece of Content includes the hyperlink to its Primary Source. We have just arranged that in our platform for Educational Purposes only. All the Copyrights and Trademarks belong to their Rightful Owners and all Materials to their Authors. If you are the Content owner and do not want us to publish your materials on our Website, please get in touch with us by email – [email protected]; we will remove the Content from our Website.

Leave a Reply